Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Zn-a-1041
2. 2414056-31-6
3. 5-[(4r)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-6-methoxy-n-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine
4. Perzebertinib [inn]
5. Orb2565014
6. Un8tm5120c
7. Schembl21807999
8. Gtpl13741
9. Ptkrhbxnndlrpo-oaqylsrusa-n
10. Bdbm612264
11. Bdbm612287
12. Us11723908, Example 37
13. Us11723908, Example 77
14. Zna-1041
15. Ex-a11170
16. Zn-1041
17. Example 31 [wo2020057511a1]
18. Hy-163428
19. Cs-1016770
20. (r)—n-(4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)-3-methylphenyl)-5-((3,3-difluoro-1-(methyl-d3)piperidin-4-yl)oxy)-6-(methoxy-d3)quinazolin-4-amine
21. (s)-n-(4-([1,2,4]-triazolo[1,5-c]pyrimidin-7-yloxy)-3-methylphenyl)-5-((3,3-difluoro-1-methylpiperidin-4-yl)oxy)-6-(methoxy-d3)quinazolin-4-amine
22. 4-quinazolinamine, 5-[[(4r)-3,3-difluoro-1-methyl-4-piperidinyl]oxy]-6-methoxy-n-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]-
23. 5-[[(4r)-3,3-difluoro-1-methyl-4-piperidinyl]oxy]-6-methoxy-n-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]-4-quinazolinamine
24. 5-{[(4r)-3,3-difluoro-1-methylpiperidin-4-yl]oxy}-6-methoxy-n-{3-methyl-4-[([1,2,4]triazolo[1,5-c]pyrimidin-7-yl)oxy]phenyl}quinazolin-4-amine
| Molecular Weight | 548.5 g/mol |
|---|---|
| Molecular Formula | C27H26F2N8O3 |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 112 |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 848 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
26
PharmaCompass offers a list of Perzebertinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Perzebertinib manufacturer or Perzebertinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Perzebertinib manufacturer or Perzebertinib supplier.
A Perzebertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Perzebertinib, including repackagers and relabelers. The FDA regulates Perzebertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Perzebertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Perzebertinib supplier is an individual or a company that provides Perzebertinib active pharmaceutical ingredient (API) or Perzebertinib finished formulations upon request. The Perzebertinib suppliers may include Perzebertinib API manufacturers, exporters, distributors and traders.
Perzebertinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Perzebertinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Perzebertinib GMP manufacturer or Perzebertinib GMP API supplier for your needs.
A Perzebertinib CoA (Certificate of Analysis) is a formal document that attests to Perzebertinib's compliance with Perzebertinib specifications and serves as a tool for batch-level quality control.
Perzebertinib CoA mostly includes findings from lab analyses of a specific batch. For each Perzebertinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Perzebertinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Perzebertinib EP), Perzebertinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Perzebertinib USP).
